Nucleic acid testing guidance
This article was originally published in The Gray Sheet
Executive Summary
Blood banks should implement recommendations from FDA 1guidance on NAT in whole blood and blood components (including source plasma and source leukocytes) within six months of Oct. 28 publication in the Federal Register, the agency advises. Pertaining to nucleic acid tests for HIV-1 and hepatitis C virus, the document updates an April 2002 draft guidance, combining it with a December 2001 guidance on NAT testing in plasma. The consolidated guidance features recommendations for donor screening and reporting requirements for licensed blood and plasma establishments. The new document also addresses product labeling and disposition...
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.